|
|
News Breaks | | | | January 17, 2013 | | 06:58 EDT |  | MJN | Mead Johnson downgraded to Neutral from Overweight at JPMorgan
JPMorgan lowered Mead Johnson estimates and downgraded shares due to sales concerns driven by difficult comps in China, inconsistent market share gains, lost contracts, and challenges in Europe. Price target lowered to $68 from $71. | |
|
News For MJN From The Last 14 Days Check below for free stories on MJN the last two weeks. |
|
|
| May 23, 2013 | | 08:14 EDT |  | MJN | Carter's
Global Consumer Products Analysts discuss the possibility of China retiring the one-child policy within the year and potential implications for consumer products on an Analyst/Industry conference call. Relevant covered companies JNJ, PG, PFE, ABT, KMB, MJN and CRI which may be impacted and discussed on the Analyst/Industry conference call to be held on May 23 at 10 am. | | | May 14, 2013 | | 17:48 EDT |  | MJN | Lone Pine gives quarterly update on stakes
NEW STAKES: Valeant Pharmaceuticals (VRX), Virgin Media (VMED), Thermo Fisher Scientific (TMO), CME Group (CME), and Liberty Media (LMCA). INCREASED STAKES: Mead Johnson Nutrition (MJN), News Corp (NWSA), Intuitive Surgical (ISRG), Monsanto (MON), and Qualcomm (QCOM). DECREASED STAKES: Cognizant Technology Solutions (CTSH), Equinix (EQIX), Ralph Lauren (RL), Disney (DIS), and Oceaneering International (OII). LIQUIDATED STAKES: Facebook (FB), Crown Castle (CCI), Accretive Health (AH), Informatica (INFA), and NetEase (NTES). | |
|
|
|
|
|
|
